glp 1 glucagon like peptide 1 Possible mechanisms of action of glucagon-like peptide-1 receptor agonists on blood pressure beyond body weight Central glucagon-like peptide 1 receptor
Description
Works Cited GLP-1s, Alcohol Use, Addiction & Reward Pathways Hendershot, C

10.2337/dc12-2713
doi: 10.1016/S2213-2600(19)30198-5, 2

"Novo Nordisk A/S: Ozempic (semaglutide) approved in the EU for the treatment of type 2 diabetes" (Press release)

A brand that deflects or can't provide it is equally informative
